FTO and obesity due to melanocortin 4 receptor deficiency: The FTO gene polymorphism is associated with an increase in the risk of obesity, as well as type 2 diabetes, heart failure, coronary heart disease, lifetime all-cause and ischemic stroke, hypertension, dyslipidemia, metabolic syndrome, and mortality.